SHP099, which was cell-loaded, facilitated the long-lasting reduction of the PD-1/PD-L1 signaling and elevated T-cell activity.110In vivo study shows that tumor-homing T lymphocytes can travel with the cargo, boosting their tumor accumulation. This evidence concerns the gene CD274 and neoplasm.